Lung cancer brain mets trial halted after just 3 patients
NCT ID NCT05746481
First seen Jan 23, 2026 · Last updated May 22, 2026 · Updated 16 times
Summary
This study tested a combination of two immunotherapy drugs (tiragolumab and atezolizumab) in people with a type of lung cancer that had spread to the brain but wasn't causing symptoms. The goal was to see if the drugs could control the brain tumors and delay the need for radiation. Only 3 people enrolled before the study was stopped early, so we don't have enough information to know if the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
Conditions
Explore the condition pages connected to this study.